SYNCOPE ASSESSMENT AND TILT TESTING
It is not just a simple faint
WHAT IS SYNCOPE?
Syncope is defined as transient loss of consciousness (TLOC) due to cerebral hypoperfusion. 
Although characterized by swift onset, short duration, and spontaneous complete recovery , “Syncope is an alarming event carrying the possibility of serious outcomes” , including potentially life-threatening heart condition and sudden cardiac death (SCD). [2.3]
FACTS & PREVALENCE
50% of the population will faint at least once in their lifetime. 
Syncope presents across all age groups
Syncope is frequent which causes high financial costs
Syncope accounts for up to 3% of all emergency department (ED) visits5, however approximately 35% of patients with syncope remain undiagnosed in the ED. 4
Syncope is a diagnostic challenge with complex underlying mechanisms 2,8, requiring multidimensional approaches and individualized patient management.
- In many cases an efficient initial syncope evaluation can lead to diagnosis and start of treatment. 
- In cases with uncertain diagnosis and suspected cardiac origin, cardiac evaluation is performed. 
- In all other cases with frequent or severe episodes, cardiovascular autonomic function tests are recommended. This makes the majority of the patients. 
- Head up Tilt Test (HUT) provides high diagnostic yield and is recommended by the ESC guidelines in case of suspicion of syncope after an initial inconclusive evaluation. [1,7]
CONTINUOUS MEASUREMENTS FOR CARDIOVASCULAR AUTONOMIC FUNCTION TESTS
As the onset of syncope happens extremely fast  only continuous measurements are helpful to caputure an event.
- Cardiovascular autonomic function tests require synchronized measurement of ECG (min 3 leads) and blood pressure, both in a continuous manner. 
- Beat-to-beat blood pressure monitoring is recommended in several guidelines and expert consenses due to “the context of syncope blood pressure (BP) can change substantially in a few seconds”. 
- “Conventional intermittent BP measurements allow one measurement per minute at best and are therefore unsuitable for syncope assessment.” 
“Our patients seek solutions, not only explanations.“ 
“If I had the option to ask the industry for one thing in the future, it would be to have a device that can measure blood pressure at the time of syncope. This is my most important requirement.” [ Prof. Michele Brignole, Italy ]
EASY TO USE INNOVATIVE TOOLS
With more than 20 years experience CNSystems provides you with state-of-the-art devices for high level syncope assessment.
- Continuous blood pressure measurement from the unique CNAP® finger sensor
- Advanced hemodynamic evaluation using CNAP® HD technology ) – non-invasive
- Synchronized patient signals (incl. wireless 12-lead ECG)
- Truly continuous recording when it matters most
TASK FORCE® TOUCH CARDIO
ALL YOU NEED TO SUPPORT YOUR CARDIOVASCULAR ASSESSMENT
- 24″ Touchscreen
- Combination of CNAP® BP and NBP
- Advanced hemodynamics using CNAP® HD technology
- Optional 12-channel ECG
- Accessory storage
- 12-channel ECG
- Pulse Rate
- Continuous Blood Pressure
- Cardiac Output
- Systemic Vascular Resistance
- Analog Input/Output signals
- Easy & quick setup through unique finger sensor design
- New Forearm Controller with integrated sizing tool
- New Forearm Strap for safe & error-free fixation
- Disinfectable finger sensor material
- All parameters (BP, CO, SV, SVR..) from one sensor – no ICG electrodes required
- Wireless Bluetooth communication
- Electrode Contact Check
- State-of-the-art interface for smart user interaction with “touch” operation
- Integrated screenshot tool
- Set markers & comments at any time
- Easy reporting & data export
- Analog input/output interface
- Post Processing tool easy data review & documentation (paperless)
- Wireless printer support
- Wireless connection to your network drive
SYNCOPE & TILT TESTING - USEFUL LINKS
There are fantastic platforms available treating the syncope topic. Find details on efficient diagnosis and treatment.
Do you have more questions?
We are always happy to help!
 Brignole, M. et al. 2018 ESC Guidelines for the diagnosis and management of syncope. European Heart Journal vol. 39 1883–1948 (2018).
 Sutton, R., Ricci, F. & Fedorowski, A. Risk stratification of syncope: Current syncope guidelines and beyond. Auton. Neurosci. 238, 102929 (2021).
 Heartrhythmalliance: STARS. Take fainting to heart. WebPage (2022) https://www.heartrhythmalliance.org/stars/uk/take-fainting-to-heart
 Sheldon, R. S. et al. 2015 Heart Rhythm Society Expert Consensus Statement on the Diagnosis and Treatment of Postural Tachycardia Syndrome, Inappropriate Sinus Tachycardia, and Vasovagal Syncope HHS Public Access. Hear. Rhythm 12, 41–63 (2015).
 Peeters, S. Y. G., Hoek, A. E., Mollink, S. M. & Huff, J. S. Syncope: risk stratification and clinical decision making. Emerg. Med. Pract. 16, 1–22; quiz 22–3 (2014).
 Goldberger, Z. D. et al. ACC/AHA/HRS Versus ESC Guidelines for the Diagnosis and Management of Syncope: JACC Guideline Comparison. J. Am. Coll. Cardiol. 74, 2410–2423 (2019).
 Barón-Esquivias, G. et al. Head-up tilt test diagnostic yield in syncope diagnosis. J. Electrocardiol. 63, 46–50 (2020).
 Dan, G. A. et al. Contemporary management of patients with syncope in clinical practice: an EHRA physician-based survey. Europace 22, 980–987 (2020).
 Thijs, R. D. et al. Recommendations for tilt table testing and other provocative cardiovascular autonomic tests in conditions that may cause transient loss of consciousness. Auton. Neurosci. (2021) doi:10.1016/j.autneu.2021.102792.